NCT01130636View on ClinicalTrials.gov

Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Influenza
Interventions
DRUG

Oseltamivir

Lactating women who present with clinical symptoms indicative of influenza will receive immediate treatment with oseltamivir (Tamiflu® 75 mg hard capsules) at a standard dose of 75 mg twice daily.

Trial Locations (2)

2921

Selye János Hospital, Department of Obstetrics and Gynecology, Komárom

H-4032

DEOEC University of Debrecen, Clinic of Obstetrics and Gynecology, Debrecen

Sponsors
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Pharmahungary Group

INDUSTRY

NCT01130636 - Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation | Biotech Hunter | Biotech Hunter